Last reviewed · How we verify

NCT05963815: Spine PROMCO

The Spine PROMCO Study

Recruiting now Last updated 28 September 2023
What this trial tests

trial testing Spine surgery in Lumbar Disc Herniation in 4,000 participants. Currently enrolling.

Timeline
13 January 2023
Primary endpoint
13 January 2030
13 January 2030

Quick facts

Lead sponsorPark Medical centrum
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment4,000
Start date13 January 2023
Primary completion13 January 2030
Estimated completion13 January 2030
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Park Medical centrum

Who can join

Adults 18 to 80, any sex, with Lumbar Disc Herniation or Spondylolisthesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our primary objective is to design a cohort to determine the treatment outcome of different surgical interventions of the degenerative lumbar spine highlighting the expediency and value of the current surgical treatment program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Spine surgery

Trials testing the same drug.

Other recruiting trials for Lumbar Disc Herniation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05963815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing